- $12.35bn
- $11.76bn
- $2.94bn
Brief: Globus Medical Q2 Adjusted EPS USD 0.63 Vs. IBES Estimate USD 0.59
Globus Medical Inc expected to post earnings of 59 cents a share - Earnings Preview
Solid Q2 medtech utilization trend should extend to H2 - Truist
Globus Medical rises on FDA nod for spine correction device
Brief: Globus Medical Announces FDA Approval For Its Non-Fusion Scoliosis Correction System, The Latest Advancement For Young Patients With Idiopathic Scoliosis
Globus Medical Inc reports results for the quarter ended in March - Earnings Summary
Brief: Globus Medical Reports First Quarter 2023 Results
Brief: Globus Medical Q1 adjusted EPS USD 0.53
Brief: Globus Medical - Entered Into An Agreement And Plan Of Merger
Brief: Nuvasive Says Co, Globus Medical Each Got Request For Additional Info From FTC
Globus Medical Inc expected to post earnings of 51 cents a share - Earnings Preview
Brief: Globus Medical Shareholders Approve Share Issuance For Merger With Nuvasive
Brief: Nuvasive Shareholders Approve Merger Agreement With Globus Medical
Brief: Globus Medical- Five Complaints Have Been Filed By Nuvasive Stockholders Against Nuvasive And Its Directors Pursuant To Deal With Co
Brief: Nuvasive Inc - Proxy Advisory Firm Glass Lewis Joins Iss In Recommending Nuvasive Shareholders Vote "For" Proposed Merger With Globus Medical
Brief: Independent Proxy Advisory Firm ISS Recommends NuVasive Shareholders Vote "For" Proposed Merger With Globus Medical
Brief: Globus Medical Inc - Pursuant To Proposed Acquisition Of Nuvasive By Co, Co Re-Filed Hart-Scott-Rodino Filing On April 3, 2023
U.S. RESEARCH ROUNDUP-Globus Medical, Philip Morris International, Vail Resorts
Globus Medical Inc reports results for the quarter ended in December - Earnings Summary